• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The World Market for Tissue Diagnostics and Cell-Based Diagnostics: Forecasts to 2018 (Histology and Cytology Tests, in situ hybridization (ISH), HPV Tests, Flow Cytometry, Digital Pathology/Image Cytometry, Hematology Cell Assays, Immunohistochemistry, CTC and Other Tests)

$995.00 – $1,990.00

Clear
SKU: KLI5389372 Categories: Diagnostics Market Research, Oncology & Hematology Market Reports Pages: 433
  • Description
  • Table of Contents
  • Latest reports

Description

Histology and cytology tests are essential for identifying cancer, inherited, infectious disease and other diseases.  This report focuses on tissue and cell diagnostic assays and technologies, providing the world markets for histology and cytology diagnostics for the current market and forecasted to 2018.  All of the technologies and applications discussed in this report share the characteristic that they start with tissue or cell specimens.  Global revenues are provided, broken out type of technology, including:
  •  Digital Pathology 
  •  Pap Smear 
  •  HPV Tests
  •  Flow Cytometry
  •  Circulating tumor cells (CTCs)
  •  Hematology (cell assays)
  •  In situ hybridization (ISH)
  •  Immunohistochemistry (IHC)
  •  Stains [non-Pap]
  • Traditional Histology
Along with standard technologies are now being applied in this field, including MS mass spectrometry, next-generation sequencing, CTCs, and others.     Advanced products in tissue and cell testing are still under development.
A global report, revenues for the overall  tissue diagnostics market are broken out by geographical region for 2013 and 2018, covering
  •  North America
  •  Europe
  •  Asia
  •  Rest of World
In the past, tissue and cell diagnostics work had been highly labor intensive and subjective in results.  This is no longer the case.  The procedures have been changed in some part by the introduction of automated processes and  digital analysis, and the development of cancer gene and HPV molecular tests.
Tissue diagnostics is a rapidly growing market driven by growth in global HPV diagnostics,  new precision cancer treatment techniques, and novel companion diagnostic tests for drugs.   Flow cytometry platforms have been available for many years.  From flow cytometry and slide preparation through analysis, all the way to result reporting, combined and automated solutions enable faster turn-around time while providing standardized results.
The report profiles key companies in the industry, including
  •  20/20 GeneSystems, Inc.
  •  3DHISTECH Ltd.
  •  Abbott Laboratories
  •  Abcam plc
  •  AB SCIEX (A Danaher Corporation company)
  •  Adaptive Biotechnologies Corporation
  •  AdnaGen GmbH (An Alere Company)
  •  Advanced Cell Diagnostics
  •  Affymetrix, Inc.
  •  Agena Bioscience Inc.
  •  Agendia BV
  •  Agilent Technologies Inc.
  •   Aurora Interactive
  •  AutoGenomics, Inc.
  •  Aviva BioSciences Corporation
  •  Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  •  Becton Dickinson and Co. (BD)
  •  Biocare Medical, LLC
  •  Biocartis S.A.
  •   Bio-Rad Laboratories, Inc.
  •   Bruker Corporation
  •  Cancer Genetics, Inc.
  •  Canopus Bioscience Ltd.
  •  Caris Life Sciences
  •   CellaVision AB
  •   Dako A/S (An Agilent Technologies Company)
  •  Danaher Corporation
  •   DiaTech Oncology
  •   Elitech Group
  •  EMD Millipore (Merck Millipore)
  •  Enzo Biochem, Inc.
  •  Epic Sciences, Inc.
  •  Fluidigm Corporation
  •  GE Healthcare
  •   Hologic, Inc.
  •  HORIBA Medical
  •   Janssen Diagnostics
  •  Leica Biosystems Inc. (Part of Danaher Corporation)
  •  Leica Microsystems (A Danaher Company)
  •  LeucoDx Inc.
  •  Life Technologies Corporation (Acquired by Thermo Fisher Scientific Inc.)
  •  MDxHealth SA
  •   Olympus Group
  •  Omnyx
  •   Oxford Gene Technology
  •  Panagene Inc.
  •  PerkinElmer, Inc.
  •  Protea Biosciences Group, Inc.
  •  Qiagen N.V.
  •  QuanDx
  •  QuantuMDx Group
  •  Rarecells SAS
  •  Response Genetics, Inc.
  •  Rheonix, Inc.
  •  Roche Diagnostics
  •   Siemens Healthcare Diagnostics
  •  Ventana Medical Systems Inc. (Member of the Roche Group)
And many other companies…
Market analyses in this report cover world markets for tissue and cell diagnostics. However, the reader will find a bias toward the developed areas of the globe — North America, Japan and Western Europe, the areas in which most tissue and cell diagnostic testing is currently performed. The information presented is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author’s industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.

Table of Contents

ONE: EXECUTIVE SUMMARY

Overview

Scope and Methodology

Market Overview

Future Prospects in the Tissue and Cell Diagnostics Market

TWO: INTRODUCTION

Overview of Tissue and Cell Diagnostics

Histology and Cytology

Tissue and Cell Diagnostics

Point-of-View

THREE: TISSUE AND CELL ANALYSIS TECHNOLOGIES

Types of Specimens

Microscopy

Cell-Based Assays; Cellular Imaging Systems and High Content Screening (HCS)

Hematology Analyzers

Stains

Antibody-Based Technologies

Immunohistochemistry (IHC)

Flow Cytometry

Chromosome Analysis (Karyotyping)

Molecular Diagnostic Analysis of Tissues and Nucleic Acid from Tissues

Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)

Polymerase Chain Reaction (PCR) to Detect Biomarkers in Tissue Specimens

Analysis of Gene Expression Patterns (“Gene Signatures”)

Next Generation Sequencing

Tissue Microarrays

Circulating Tumor Cells (CTCs)

Digital Pathology and Image Cytometry

Histology Laboratory Automation

Mass Spectrometry – Imaging and Analysis of DNA

FOUR: TISSUE AND CELL DIAGNOSTICS APPLICATIONS

Research, Drug Discovery and Development

In Vitro Diagnostics

FIVE: DISEASE APPLICATIONS – TISSUE AND CELL DIAGNOSTICS

Cancer

Cancer Screening – Pap Smear and Human Papillomavirus (HPV) Testing

Diagnosis of Cancer

Pharmacodiagnostics

Prenatal Testing

Other Disease Applications of Tissue and Cell Diagnostics

SIX: DEALS – TISSUE AND CELL DIAGNOSTIC COMPANIES

Investments and Financing Agreements for Tissue and Cell Diagnostic Companies

Agreements with Other Companies

Acquisitions of Tissue and Cell Diagnostics Companies

Selected Other Agreements

SEVEN: TISSUE/CELL DIAGNOSTICS – MARKET DRIVERS AND CHALLENGES

Tissue/Cell Diagnostics Market Drivers

Issues and Hurdles Faced by Companies Selling to the Research Market

Issues and Hurdles Faced by In Vitro Diagnostic Companies

Increasing Numbers of Tests on Small Biopsy Specimens

Future Prospects

EIGHT: MARKET ANALYSIS

Tissue and Cell Diagnostics Market by Technology

Tissue and Cell Diagnostics Market by Geographical Distribution

Tissue and Cell Diagnostics Market by Disease Indication

Tissue and Cell Diagnostics – Proprietary Tests from Companies with CLIA-Certified

Laboratories

Analysis of Tissues and Cells in the Life Sciences

Prospects for Growth of the Tissue and Cell Diagnostics Market

NINE: COMPANY PROFILES: COMPANIES MARKETING OR DEVELOPING TISSUE DIAGNOSTIC PRODUCTS OR SERVICES

20/20 GeneSystems, Inc

3DHISTECH Ltd

Abbott Laboratories

Recent Revenue History

Company Overview (Focusing on Diagnostics, Especially Immunoassays)

Abcam plc

Recent Revenue History

Company Overview

AB SCIEX (A Danaher Corporation Company)

Adaptive Biotechnologies Corporation

Adnagen GmbH (An Alere Company)

Advanced Cell Diagnostics

Affymetrix, Inc.

Recent Revenue History

Company Overview (Focusing on Proteomics Activities)

Agena Bioscience Inc.

Agendia NV

Agilent Technologies Inc.

Recent Revenue History

Company Overview

Amoy Diagnostics Co., Ltd.

ANGLE plc

ApoCell, Inc.

Apogee Flow Systems Ltd.

Apollo PACS, Inc.

Applied Cytometry

Applied Spectral Imaging, Inc.

Arbor Vita Corporation

Asuragen, Inc.

Diagnostic Products

Clinical Lab

Genomic Services

Companion Diagnostics

Aurora Interactive

AutoGenomics, Inc.

Aviva BioSciences Corporation

Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)

Recent Revenue History

Company Overview

Hematology

Flow Cytometry

Becton, Dickinson and Company (BD)

Recent Revenue History

Company Overview

Biocare Medical, LLC

Biocartis SA

BioCEP Ltd

Biocept, Inc.

BioDot Inc.

BioFluidica, Inc

BioGenex

BioMarker Strategies

bioMérieux SA

Recent Revenue History

Company Overview

BioMosaics Inc.

Bio-Rad Laboratories, Inc.

Recent Revenue History

Company Overview

Bio SB

BioTek Instruments, Inc.

bioTheranostics (A bioMérieux Company)

BioView Ltd.

Bruker Corporation

Recent Revenue History

Company Overview

Cancer Genetics, Inc.

Recent Revenue History

Company Overview

Canopus Bioscience Ltd.

Caris Life Sciences

Carl Zeiss AG

Carl Zeiss Microscopy GmbH

Recent Revenue History

Company Overview

Castle Biosciences Inc.

CCC Diagnostics, LLC

CDx Diagnostics

Celerus diagnostics, Inc.

CellaVision AB

CellTraffix, Inc.

Cellular Dynamics International

Celula, Inc.

Cernostics

Cirdan Imaging Ltd

Cisbio Bioassays

Clarient Diagnostic Services, Inc. (A GE Healthcare Company)

Clearbridge BioMedics

Clontech Laboratories, Inc (Member of the Takara Bio Group)

CombiMatrix Corporation

Recent Revenue History

Company Overview

Creatv MicroTech, Inc.

CymoGen Dx, LLC (Being Acquired by Biocare Medical, LLC)

Cynvenio Biosystems, Inc.

Cytek Development Inc.

CytoTrack ApS

Dako A/S (An Agilent Company)

Recent Revenue History

Company Overview

Danaher Corporation

Recent Revenue History

Company Overview

Definiens AG

DiaCarta Inc.

DiaTech Oncology

DiscoveRx Corporation

ELITech Group

EMD Millipore (Merck Millipore)

Recent Revenue History

Company Overview

Enzo Biochem, Inc

Enzo Life Sciences, Inc

Enzo Clinical Labs, Inc.

Recent Revenue History

Company Overview

Epic Sciences, Inc.

Fluidigm Corporation

Recent Revenue History

Company Overview

Fluxion Biosciences, Inc.

Foundation Medicine, Inc.

Recent Revenue History

Company Overview

GE Healthcare

Recent Revenue History

Company Overview

GeneCentric Diagnostics, Inc.

Genomic Health, Inc.

Recent Revenue History

Company Overview

HemoGenix

HistoGeneX

Hologic, Inc.

Recent Revenue History

Company Overview

HORIBA Medical

Recent Revenue History

Company Overview

HTG Molecular Diagnostics

Huron Technologies International Inc.

Icellate AB

Ikonisys, Inc.

ImaBiotech SAS

ImaBiotech Corp

IMMCO Diagnostics, Inc. (A Trinity Biotech Company)

IncellDx, Inc.

Indica Labs, Inc.

Insight Genetics, Inc.

IntelliCyt Corporation

Iris BioTechnologies Inc.

Recent Revenue History

Company Overview

Janssen Diagnostics

Janssen Diagnostics BVBA

Janssen Diagnostics, LLC (Oncology Diagnostics)

Leica Biosystems Inc. (Part of Danaher Corporation)

Leica Microsystems (A Danaher Company)

LeucoDx Inc.

Life Technologies Corporation (Acquired by Thermo Fischer Scientific Inc.)

Recent Revenue History

Company Overview

MDxHealth SA

Recent Revenue History

Company Overview

Metamark Genetics, Inc.

MetaSystems GmbH

MetaSystems Group, Inc.

Miltenyi Biotec GmbH

Molecular Devices, LLC (A Danaher Company)

MolecularMD Corporation

Monogram Biosciences (LabCorp Specialty Testing Group)

Multiplicom NV

Myriad Genetics, Inc.

Recent Revenue History

Company Overview

NanoString Technologies, Inc.

Recent Revenue History

Company Overview

Nikon Corporation

Nikon Instruments Inc.

Recent Revenue History

Company Overview

Nodality, Inc.

Norchip AS

Olympus Group

Recent Revenue History

Company Overview

Omnyx

OncoHealth Corp.

OncoPlex Diagnostics (OncoPlexDx)

Oxford Cancer Biomarkers Ltd

Oxford Gene Technology

Panagene Inc.

PerkinElmer, Inc.

Recent Revenue History

Company Overview

Quantitative Pathology Imaging and Analysis Systems

Cellular Imaging and Analysis Systems

Histological Analysis

Protea Biosciences Group, Inc.

Recent Revenue History

Company Overview

QIAGEN N.V.

Recent Revenue History

Company Overview

QuanDx

QuantuMDx Group

Rarecells SAS

Response Genetics, Inc.

Recent Revenue History

Company Overview

Rheonix, Inc.

Roche Diagnostics

Recent Revenue History

Company Overview

ScreenCell

Siemens Healthcare Diagnostics

Recent Revenue History

Company Overview

Sigma-Aldrich Corporation

Recent Revenue History

Company Overview

Silicon Biosystems

Sony Biotechnology Inc.

Span Diagnostics Ltd.

Sysmex Corporation

Recent Revenue History

Company Overview

TeloVISION, LLC

Theranostics Health Inc.

Thermo Fisher Scientific, Inc.

Recent Revenue History

Company Overview

Ventana Medical Systems, Inc. (Member of the Roche Group)

Veracyte, Inc.

Recent Revenue History

Company Overview

Vitatex Inc.

WaveSense, Inc.

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Molecular Imaging Agents and Systems – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

    $3,500.00 – $7,000.00
  • Placeholder image

    In Vitro Diagnostic Tests and Systems: The World Outside the United States

    $596.00 – $1,192.00
  • Placeholder image

    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    $1,500.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
X-Ray and Digital X-Ray: World Market Analysis, Forecasts to 2018MRI: World Market Analysis, Forecasts to 2018
Scroll to top